Out-licensing: Genito-urinary/Gender Related Medicine Female

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing
Browse

Licensing opportunities

Displaying 1..10 of 19 - per page Next page
Order by

Neo-Penotran® topical broad spectrum anti-infective vaginal pessary and cream for the treatment of three main types of vaginal infections and mixed forms of vaginitis.

Each Dose of Neo-Penotran® contains a combination of Metronidazole and Miconazole Nitrate in therapeutic concentrations for the local treatment of the treatment three main types of vaginal infections and mixed forms of vaginitis. More

Amphora/ACIDFORM Microbicide

pH maintenance, Spermicide, Microbicide Lubricant More

Hyalobarrier®

Hyaluronan based gel for prevention and reduction of adhesion formation in the abdominal pelvic area More

Instead® Softcup™ - Revolutionary Menstrual Protection

Superior Alternative to Pads and Tampons More

Phytohealth Corporation: PH3 (PHN031, PHN033) - For osteoporosis and diabetic vascular complications

Patented technology regarding new and safe mechanism with the active substance PH3 for the indications of osteoporosis and diabetic vascular complications. More

Diagnostic Method to Detect Endometriosis

A non-invasive development of a test for the diagnosis and monitoring of endometriosis. More

First trimester pre-eclampsia diagnostic test

A test that has shown the ability to diagnose pre-eclampsia from first trimester serum samples with 67% sensitivity More

Biomarkers For the Early Detection of Pre-eclampsia

Western inventors have identified a group of 12 differentially expressed proteins in Preeclampsia (PE) patients using a state-of-art proteomics based approach. More

Out-licensing of modified-release gabapentin, a non-hormonal prescription product for the treatment of menopausal hot flushes/flashes and related symptoms associated with cancer therapies.

Exclusive license for use of gabapentin in the above indications in EU, Canada, Australia, New Zealand. US Phase 3 trials of MR-gabapentin for menopause by PharmaNova’s US licensee (Depomed, Inc) will complete in 3Q 2009; Co-promotion in US is possible. More

Measuring Fifteen Endogenous Estrogens Simultaneously in Human Urine by High-Performance Liquid Chromatography-Mass Spectrometry

A validated high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry method for measuring the absolute quantities of fifteen endogenous estrogens and their metabolites in human urine. More

Displaying 1..10 of 19 - per page Next page
Order by

Your selection

Therapeutic target: Genito-urinary del; Gender related medicine female del

Browse By

Industry sector: Animal health; Biotechnology; Diagnostic; Drug delivery; Drug discovery; Medical device; Pharmaceutical; Research tools
Therapeutic target: Amenorrhea; Contraception, female; Dysmenorrhea; Dysoplasia, cervical; Endometriosis; Female arousal disorder; Gynecological disorder (other); Menopause; Pelvic inflammatory disease; Polycystic ovary syndrome; Pregnancy; Sjogren's syndrome; Turner's syndrome; Women's health (other)
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us